论文部分内容阅读
目的:分析武汉市24所医院2005～2007年医保甲类药品使用情况及用药趋势,为制定医保政策及参保医院合理用药提供参考。方法:对武汉市24所医院购入的医保甲类药品的购药金额、购入品种进行统计分析。结果:购入甲类药品金额占总金额比例及种类均呈下降趋势,甲类药品在利尿、脱水药物以及作用于消化系统药物中所占百分比最高;下降幅度最大的为抗感染药物和抗恶性肿瘤药物,同期上升幅度最大的是影响生长代谢机能药物(其中主要包括降血糖药物)及心血管系统用药。结论:将《国家基本药物目录》和《国家基本医疗保险药品目录》合二为一,有助于促进临床合理用药;应将儿科用药纳入医保范围,并将药物经济学评价列为能否进入该目录的必要条件,从而达到宏观调控不合理药费支出的目的。
OBJECTIVE: To analyze the usage situation and medication tendency of Medicines and A Medicines in 24 hospitals in Wuhan from 2005 to 2007, and to provide reference for formulating Medicare policies and rational use of Medicines in participating hospitals. Methods: The purchase amount of medicines and drugs purchased from 24 hospitals in Wuhan were analyzed statistically. Results: The proportions and types of drugs purchased for Class A accounted for the largest proportion of the total amount. The prices of Type A drugs in diuretics, dehydration drugs and drugs acting on the digestive system were the highest. The largest decrease was in anti-infective drugs and anti-malignant Oncology drugs, the largest increase over the same period is the impact of growth and metabolism of drugs (including mainly hypoglycemic drugs) and cardiovascular system medication. Conclusion: Combining the “National Essential Drug List” with the “National Basic Medical Insurance Drug List” will help to promote rational drug use in clinical practice. Pediatric medicines should be included in the scope of medical insurance, and pharmacoeconomic evaluation should be included The directory of the necessary conditions, so as to achieve the purpose of macro-control unreasonable drug expenditures.